An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-9 | Issue-02
A Comparative Study between NSAID with McKenzie Exercise versus NSAID Treatment in Ankylosing Spondylitis
Dr. Iftakharul Alam, Dr. Nusrat Neherin Khan, Dr. Suriya Shahaly, Dr. Reshad Aldin Ahmed, Prof. Dr. A K M Salek, Prof. Dr. Taslim Uddin
Published: Feb. 8, 2023 | 183 136
DOI: 10.36347/sasjm.2023.v09i02.002
Pages: 66-73
Downloads
Abstract
Background: McKenzie method of mechanical diagnosis and therapy (MDT)) is a technique primarily used in physical therapy. It was developed in the late 1950s by New Zealand physiotherapist Robin McKenzie. In 1981 he launched the concept which he called Mechanical Diagnosis and Therapy (MDT) a system encompassing assessment, diagnosis and treatment for the spine and extremities. On the other hand, Ankylosing spondylitis (AS) is a type of arthritis that causes lower back pain, hip pain and a stiff back which causes due to overtime work, vertebrae in the spinal column. In relieving pain and inflammation in AS patients, non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed drugs in the world. Aim of the Study: The aim of this study was to compare between NSAID with McKenzie exercise versus NSAID treatment in Ankylosing spondylitis. Methods: This was a comparative experimental study which was conducted in the department of Physical Medicine and Rehabilitation, BSMMU, Dhaka, Bangladesh from October 2019 to September 2020. The study was approved by Institutional Review Board (IRB) of BSMMU. A total of 112 patients with ankylosing spondylitis were selected who were divided into two groups. 56 patients were allotted in group A (NSAID group) and another 56 were allotted in group B (NSAID with McKenzie exercise). All comparative data were analyzed and disseminated by using MS Excel and SPSS version 23.0. Results: The mean age was 28.02±5.86 years in group A whereas 28.8±5.94 years in group B and the difference was statistically not significant (p>0.05). The mean VAS score at baseline was 34.44±2.78 in group A and 34.03±2.23 in group B, at 4 weeks 28.89±3.67 in group A and 21.23±3.57 in group B, at 8 weeks 30.59±3.69 in group A and 16.95±3.62 in group B and at 12 weeks 28.08±3.34 in group A and 15.04±3.77 in group B. The mean BASFI at baseline was 3.19±0.15 in group A and 3.51±0.18 in group B, at 4 weeks 2.99±0.15 in group A and 2.15±0.05 in .....